- Home
- VHC vs LSTA Comparison
VHC vs LSTA Comparison
Compare VHC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- LSTA
- Stock Information
- Founded
- VHC 2005
- LSTA 1980
- Country
- VHC United States
- LSTA United States
- Employees
- VHC N/A
- LSTA 26
- Industry
- VHC Multi-Sector Companies
- LSTA Misc Health and Biotechnology Services
- Sector
- VHC Miscellaneous
- LSTA Health Care
- Exchange
- VHC Nasdaq
- LSTA Nasdaq
- Market Cap
- VHC 48.2M
- LSTA 22.5M
- IPO Year
- VHC 1999
- LSTA N/A
- Fundamental
- Price
- VHC $16.31
- LSTA $2.72
- Analyst Decision
- VHC
- LSTA Strong Buy
- Analyst Count
- VHC 0
- LSTA 1
- Target Price
- VHC N/A
- LSTA $15.00
- AVG Volume (30 Days)
- VHC 27.6K
- LSTA 23.4K
- Earning Date
- VHC 08-13-2025
- LSTA 08-11-2025
- Dividend Yield
- VHC N/A
- LSTA N/A
- EPS Growth
- VHC N/A
- LSTA N/A
- EPS
- VHC N/A
- LSTA N/A
- Revenue
- VHC $3,000.00
- LSTA $1,000,000.00
- Revenue This Year
- VHC N/A
- LSTA N/A
- Revenue Next Year
- VHC N/A
- LSTA N/A
- P/E Ratio
- VHC N/A
- LSTA N/A
- Revenue Growth
- VHC N/A
- LSTA N/A
- 52 Week Low
- VHC $3.68
- LSTA $1.87
- 52 Week High
- VHC $17.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- VHC 82.28
- LSTA 52.43
- Support Level
- VHC $11.66
- LSTA $2.34
- Resistance Level
- VHC $9.05
- LSTA $3.09
- Average True Range (ATR)
- VHC 1.47
- LSTA 0.25
- MACD
- VHC 0.62
- LSTA 0.01
- Stochastic Oscillator
- VHC 89.42
- LSTA 50.67
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.